Moderna Inc (LTS:0A45)
$ 39.3575 -1.0175 (-2.51%) Market Cap: 15.50 Bil Enterprise Value: 9.98 Bil PE Ratio: 0 PB Ratio: 1.30 GF Score: 58/100

Moderna Inc at Morgan Stanley Global Healthcare Conference (Virtual) Transcript

Sep 10, 2021 / 03:45PM GMT
Release Date Price: $451.68 (+1.09%)
Matthew Kelsey Harrison
Morgan Stanley, Research Division - Executive Director

Great. Thanks, everybody, for joining us for the next session. Very pleased to have Moderna here.

Quickly before we get started, I just need to read a disclosure statement. Please note that all important disclosures, including personal holdings disclosures and Morgan Stanley disclosures appear on the Morgan Stanley public website at morganstanley.com/researchdisclosures.

So very pleased to have Stephane Bancel, who's the CEO of Moderna with us. And Stephane, I thought since you just had a big R&D review yesterday, maybe we could start off with some of the highlights from that.

Stephane Bancel
Moderna, Inc. - CEO & Director

Sure. Well, Matt, good morning and -- or good afternoon, and thank you for having us today.

So yes, yesterday, I think we kind of gave an update on our programs. I think there's basically 4 directions that the company is taking, there's 4 priorities on product side. One is to develop a pan-respiratory annual booster vaccine.

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot